Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 26, 2015 11:58 PM ET


Company Overview of Galera Therapeutics, Inc.

Company Overview

Galera Therapeutics, Inc., a clinical-stage biotechnology company, develops drugs targeting oxygen metabolic pathways. The company primarily focuses on the prevention of radiation-induced toxicity, including mucositis, and the treatment of cancer. Its small molecule dismutase mimetics mimics the activity of the human superoxide dismutase enzymes. The company was founded in 2009 and is based in Malvern, Pennsylvania.

2 West Liberty Boulevard

Suite 110

Malvern, PA 19355

United States

Founded in 2009



Key Executives for Galera Therapeutics, Inc.

Chief Executive Officer, President and Director
Age: 58
Founder, Chief Operating Officer and Director
Chief Financial Officer
Age: 66
Chief Medical Officer
Director of Business Development
Compensation as of Fiscal Year 2015.

Galera Therapeutics, Inc. Key Developments

Galera Therapeutics Appoints Thomas Dyrberg to the Board of Directors

Galera Therapeutics, Inc. announced it has completed a $37 million Series B financing. The Series B financing was led by Novo Ventures, with participation from existing investors New Enterprise Associates, Novartis Venture Fund (NVF), Correlation Ventures and Galera Angels. Dr. Thomas Dyrberg, Managing Partner of Novo Ventures, will join the Galera Board of Directors.

Galera Therapeutics, Inc. Presents at Boston CEO Conference, May-27-2015 01:00 PM

Galera Therapeutics, Inc. Presents at Boston CEO Conference, May-27-2015 01:00 PM. Venue: Four Seasons Hotel, 200 Boylston Street, Boston, MA 02116, United States. Speakers: Robert A. Beardsley, Executive Chair of the Board of Directors.

Galera Therapeutics, Inc. Presents at Boston Biotech NY/NJ CEO Conference, Nov-12-2014 12:55 PM

Galera Therapeutics, Inc. Presents at Boston Biotech NY/NJ CEO Conference, Nov-12-2014 12:55 PM. Venue: Apella, 450 East 29th Street, New York, New York, United States. Speakers: Mel Sorensen, Chief Executive Officer, President and Director.

Similar Private Companies By Industry

Company Name Region
BioDisplay Technologies, Inc. United States
International Immuno Diagnostics Inc. United States
Endogeny Bio Corporation United States
Hemera Biosciences Inc. United States
AFG Biosolutions, Inc. United States

Recent Private Companies Transactions

Private Placement
October 1, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Galera Therapeutics, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at